Latest in Research & Development

UNC Charlotte and BioCytics target cancer ‘dark genome’ with multi-omics platform

Two-year research collaboration will combine long-read sequencing, immune profiling and computational analysis to identify viral and genomic drivers of cancer and support personalised treatment decisions

Find out more
UNC Charlotte and BioCytics target cancer ‘dark genome’ with multi-omics platform

FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance

FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance

The new AI-powered platform combines autonomous digital workers, interoperable healthcare data and compliance tools to help pharmaceutical manufacturers, medical device...
See more
Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Cambridge-based biotech Mission Therapeutics has divested its Phase II-ready USP30 inhibitor MTX652 to renal specialist Dimerix in a deal worth up to $292m, allowing the company to accelerate its Parkinson’s disease pipeline
Early phase analytical strategy for biosimilars in a shifting regulatory landscape

Early phase analytical strategy for biosimilars in a shifting regulatory landscape

As FDA and EMA guidance continues to reinforce analytical comparability as the foundation of biosimilar development, investing in comprehensive early-stage characterisation is becoming essential to reduce uncertainty and improve development outcomes, says Dr Andrew J. Reason, CEO at BioPharmaSpec
AI in pharma: Practical use cases transforming research, regulatory and medical affairs

AI in pharma: Practical use cases transforming research, regulatory and medical affairs

AI and digital transformation expert Sarah Chan explores the rapidly expanding role of artificial intelligence across the pharmaceutical value chain
Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

The clinical-stage biotech has relocated to ARC Oxford, strengthening its R&D capabilities as it progresses clinical trials of its oncolytic immunotherapy candidate THEO-260 for ovarian cancer and other solid tumours
You need to be a subscriber to read this article.
Click here to find out more.
Precision medicine and the fight to revive neuroscience R&D

Precision medicine and the fight to revive neuroscience R&D

In discussion with Dr Kevin Robinson (KSR), Neurvati’s Dr Bruce Leuchter (BL) explores how biology-led development, better diagnosis and rare disease infrastructure could help to unlock stalled neuroscience programmes
Grünenthal joins genetic medicine cluster CNATM to advance RNA therapeutics

Grünenthal joins genetic medicine cluster CNATM to advance RNA therapeutics

The pain specialist has joined the Cluster for Nucleic Acid Therapeutics Munich to strengthen its oligonucleotide drug discovery capabilities and accelerate the development of genetic medicines for neurological diseases
Novogene Europe launches untargeted metabolomics service at Cambridge Omics Centre

Novogene Europe launches untargeted metabolomics service at Cambridge Omics Centre

The LC-MS workflow, built on Thermo Fisher's Orbitrap Exploris 120, adds small-molecule profiling to Novogene's genomics and transcriptomics capabilities, strengthening multiomics support for disease mechanism, biomarker and microbiome research across Europe
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Research & Development

Plan your marketing strategy with Manufacturing Chemist

Plan your marketing strategy with Manufacturing Chemist

Discover upcoming special reports, themed features and commercial opportunities to help you connect with pharmaceutical manufacturing decision-makers throughout the year
Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

The global study builds on US POINTER trial findings, testing whether adding a metabolism-targeting drug to structured lifestyle programmes can further reduce cognitive decline risk in at-risk older adults during a three-year period
BioMed X and Boehringer Ingelheim expand XSeed Labs to accelerate next-generation eye biologics research

BioMed X and Boehringer Ingelheim expand XSeed Labs to accelerate next-generation eye biologics research

A new research team at XSeed Labs will develop human retina models to improve the discovery and validation of intraocular biologics for retinal diseases
CluePoints study puts financial value on RBQM in clinical trials

CluePoints study puts financial value on RBQM in clinical trials

The newly published research quantifies RBQM's ROI, finding up to 23x returns and 8-19% shorter trial durations across oncology development
Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents

Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents

The duo will work to develop improved reagents for gene regulation research, with Abcam already integrating data from EpiCypher's CUTANA ChIC/CUT&RUN platform into its portfolio
Lonza acquires rights to Nona's TfR1 blood-brain barrier technology and expands strategic collaboration

Lonza acquires rights to Nona's TfR1 blood-brain barrier technology and expands strategic collaboration

Nona Biosciences’ BBB technology, combined with Lonza’s biologics development and bioconjugation capabilities, aims to enable development for central nervous system (CNS) therapies
Lonza expands strategic collaboration with leading US biopharmaceutical company

Lonza expands strategic collaboration with leading US biopharmaceutical company

The tailor-made comprehensive offering spans a diversified clinical and commercial portfolio of innovative modalities, including process intensification and drug product manufacturing
IMCD opens new Pharmaceutical Technical Centre in New Jersey

IMCD opens new Pharmaceutical Technical Centre in New Jersey

IMCD has launched a new Pharmaceutical Technical Centre in Allendale, New Jersey, offering advanced formulation support for solid, semi-solid and liquid dosage forms, alongside a co-located Food & Nutrition US Technical Hub
AbbVie receives positive CHMP opinion for Upadacitinib (RINVOQ) to treat adults and adolescents with non-segmental vitiligo

AbbVie receives positive CHMP opinion for Upadacitinib (RINVOQ) to treat adults and adolescents with non-segmental vitiligo

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs for those living with the chronic, unpredictable autoimmune disease
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi advances on two fronts: a new Abu Dhabi vaccine innovation centre with AI and mRNA capabilities and UK NICE backing for teplizumab, the first disease-modifying treatment for type 1 diabetes

Sponsor content

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

Brings decentralised, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
ten23 health expands excipient options for biologic drug development with an external collaboration

ten23 health expands excipient options for biologic drug development with an external collaboration

ten23 health today highlights its research collaboration with dsm-firmenich, focused on expanding excipient options for parenteral biologic drug products
IMA introduces Cognitive Manufacturing: beyond the Smart Factory

IMA introduces Cognitive Manufacturing: beyond the Smart Factory

New AI-driven architecture transforms manufacturing data into operational knowledge to support faster, more informed and more effective decision-making
ATEX zones explained: classifying hazardous areas in chemical manufacturing

ATEX zones explained: classifying hazardous areas in chemical manufacturing

When a dust explosion killed six workers at a US pharmaceutical plant in 2003, the hazard was on file. What was missing was area classification, the foundation of every...
Accelerating self-administration and homecare: SCHOTT Pharma launches large-volume prefillable glass syringe

Accelerating self-administration and homecare: SCHOTT Pharma launches large-volume prefillable glass syringe

SCHOTT Pharma’s first 5.5 ml prefillable staked-needle glass syringe is now commercially available. It is compatible with Ypsomed’s YpsoMate 5.5 large-volume...
SCHOTT Pharma launches ready-to-use polymer cartridge

SCHOTT Pharma launches ready-to-use polymer cartridge

Rising demand for sensitive biologics and patient-friendly administration calls for new drug delivery solutions. SCHOTT TOPPAC cartridge is the first polymer cartridge on...
SCHOTT Pharma and SHL Medical enhance home-based large-volume injections for patients

SCHOTT Pharma and SHL Medical enhance home-based large-volume injections for patients

SCHOTT Pharma and SHL Medical have joined forces to introduce the first large-volume cartridge in an autoinjector
Haier Biomedical introduces higher capacity benchtop centrifuge with rapid pre-cooling

Haier Biomedical introduces higher capacity benchtop centrifuge with rapid pre-cooling

Haier Biomedical – a trusted partner in reliable laboratory equipment – has introduced the LX-155T750R, its latest high-speed, benchtop centrifuge featuring ECO...
Precision on the move: one handheld device, infinite applications

Precision on the move: one handheld device, infinite applications

HBK launches DA110 handheld indicator for precise field measurements and mobile calibration
Alithea Genomics launches early access program for MERCURIUS 1536 DRUG-seq

Alithea Genomics launches early access program for MERCURIUS 1536 DRUG-seq

New ultra-high-throughput kit enables transcriptomics at screening scale for compound profiling
ACI expands HPLC portfolio with premium check valves for liquid chromatography systems

ACI expands HPLC portfolio with premium check valves for liquid chromatography systems

New aftermarket check valves provide a cost-effective, high-reliability alternative for Agilent and Waters HPLC/UPLC systems
The 7 most common process development mistakes

The 7 most common process development mistakes

At laboratory scale, processes may appear predictable, repeatable, and well understood. However this perceived level of control can be misleading

Featured companies

Since 1974, Butterworth Laboratories has provided independent, contract analytical chemistry services to the global pharmaceutical and related industries. Consequently, we are... 3P innovation is a UK-based engineering and custom automation company, delivering innovative solutions to leading major pharmaceutical and medical device companies. We support... At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable. Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life...
See more